About Cytiva Europe
PURIDIFY WAS ACQUIRED BY GE HEALTHCARE, NOW CYTIVA IN 2017
Global demand for cheaper biotherapeutics drives the need for bioprocessing cost reduction, a significant proportion of which comes from chromatography reagents and their operation.
• Puridify uses nanofibre technology to create purification solutions for biotherapeutic manufacturing.
• Puridify's chromatography reagent, FibroSelect, reduces bioprocessing costs for manufacturers.
• FibroSelect offers substantial productivity increase in purification whilst making minimal changes to current best practice.
- Focus : Manufacturer
- Industry : Biotechnology
Product portfolio of Cytiva Europe
Here you will find Cytiva Europe GmbH
See the theme worlds for related content
Topic world Cell culture technology
Cell culture technology is a central pillar in biotechnological and pharmaceutical research and development. It enables the growth and maintenance of cells under controlled laboratory conditions, providing a window into the molecular and cellular processes of life.
Topic world Cell culture technology
Cell culture technology is a central pillar in biotechnological and pharmaceutical research and development. It enables the growth and maintenance of cells under controlled laboratory conditions, providing a window into the molecular and cellular processes of life.
